REGULATION OF THE LOW AFFINITY IGE FC RECEPTOR (CD23) IN ATOPIC-DERMATITIS

被引:10
作者
HALPERN, M [1 ]
SCHWARTZ, S [1 ]
机构
[1] UNIV MICHIGAN, DEPT PEDIAT & COMMUNICABLE DIS, ANN ARBOR, MI 48109 USA
关键词
CD23; DERMATITIS; IGE; IMMUNOREGULATION; INTERFERON; INTERLEUKIN-4;
D O I
10.1159/000236411
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Alterations in the production of CD23, the IgE Fc receptor, may play a role in the etiology of atopic dermatitis and other allergic conditions. Interleukin-4 (IL-4), interferon-gamma (IFN-gamma), and interferon-alpha (IFN-alpha) are involved in coordinate regulation of CD23. IL-4 stimulates production of both CD23 and IgE. IFN-gamma also stimulates production of CD23, but suppresses production of IgE and inhibits IL-4-mediated production of CD23. IFN-alpha also suppresses these IL-4-mediated activities and, in addition, suppresses IFN-gamma-mediated stimulation of CD23 production. Changes in this coordinate regulation may be involved in the development of atopic dermatitis. Expression of CD23 by Langerhans cells is stimulated by IL,4 and IFN-gamma. Further, levels of CD23-positive T cells are elevated in atopic dermatitis subjects as compared to non-atopic controls, and observed skin changes appear to be related to changes in CD23-positive mononuclear cell populations. Coordinate regulation of CD23 by IFN-gamma and IL-4 may also be important in other allergic conditions, parasitic infections, and a variety of disease states.
引用
收藏
页码:197 / 200
页数:4
相关论文
共 33 条
[1]  
BASKAR P, 1990, J IMMUNOL, V144, P2321
[2]   INDUCTION OF FC-EPSILON-R2/CD23 ON HUMAN EPIDERMAL LANGERHANS CELLS BY HUMAN RECOMBINANT INTERLEUKIN-4 AND GAMMA-INTERFERON [J].
BIEBER, T ;
RIEGER, A ;
NEUCHRIST, C ;
PRINZ, JC ;
RIEBER, EP ;
BOLTZNITULESCU, G ;
SCHEINER, O ;
KRAFT, D ;
RING, J ;
STINGL, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (01) :309-314
[3]   GAMMA-INTERFERON PROMOTES THE RELEASE OF IGE-BINDING FACTORS (SOLUBLE CD23) BY HUMAN EPIDERMAL LANGERHANS CELLS [J].
BIEBER, T ;
DELESPESSE, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (03) :600-603
[4]   ATOPIC-DERMATITIS [J].
BROWN, MA ;
HANIFIN, JM .
CURRENT OPINION IN IMMUNOLOGY, 1990, 2 (04) :531-534
[5]   SOLUBLE CD23 IS RELEASED BY B-LYMPHOCYTES CYCLING IN RESPONSE TO INTERLEUKIN-4 AND ANTI-BP50 (CDW40) [J].
CAIRNS, J ;
FLORESROMO, L ;
MILLSUM, MJ ;
GUY, GR ;
GILLIS, S ;
LEDBETTER, JA ;
GORDON, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (03) :349-353
[6]   REGULATION OF HUMAN IGE SYNTHESIS .1. HUMAN IGE SYNTHESIS INVITRO IS DETERMINED BY THE RECIPROCAL ANTAGONISTIC EFFECTS OF INTERLEUKIN-4 AND INTERFERON-GAMMA [J].
CHRETIEN, I ;
PENE, J ;
BRIERE, F ;
MALEFIJT, RD ;
ROUSSET, F ;
DEVRIES, JE .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (02) :243-251
[7]  
DELESPESSE G, 1989, J IMMUNOL, V142, P134
[8]   LOW-AFFINITY RECEPTOR FOR IGE (FCERII, CD23) AND ITS SOLUBLE FRAGMENTS [J].
DELESPESSE, G ;
HOFSTETTER, H ;
SARFATI, M .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1989, 90 :41-44
[9]   INTERLEUKIN-4 AND INTERFERON-ALPHA AND INTERFERON-GAMMA REGULATE FC-EPSILON-R2/CD23 MESSENGER-RNA EXPRESSION ON NORMAL HUMAN B-CELLS [J].
DENOROY, MC ;
YODOI, J ;
BANCHEREAU, J .
MOLECULAR IMMUNOLOGY, 1990, 27 (02) :129-134
[10]  
FLORESROMO L, 1989, IMMUNOLOGY, V67, P547